Anti-resorptive therapy and MRONJ. A survey of the Italian Society of Periodontology and Implantology.
anti-resorptive therapy
bisphosphonates denosumab
dentists
medication-related osteo-necrosis of the jaws
periodontitis
Journal
Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565
Informations de publication
Date de publication:
29 Feb 2024
29 Feb 2024
Historique:
revised:
14
01
2024
received:
06
11
2023
accepted:
13
02
2024
medline:
1
3
2024
pubmed:
1
3
2024
entrez:
1
3
2024
Statut:
aheadofprint
Résumé
Anti-resorptive agents have been linked to the development of MRONJ in patients undergoing dental surgical procedures. This survey aims to explore the level of knowledge and experience of Italian Society of Periodontology and Implantology members in the management of patients treated with anti-resorptive agents and with the risk of developing MRONJ. An 18-item questionnaire was submitted by e-mail to the SIdP members. Statistical analyses were carried out. Continuous variables were described as mean ± standard deviation (SD) or median, and first and third quartile according to distribution's normality. Normality of data was checked with Shapiro-Wilk test. Four hundred and fifty-one questionnaires were returned by e-mail (32%). Most of the respondents were private practitioners (81.8%). Only 47.7% declared to be highly confident in managing patients on anti-resorptive therapy while 92.5% reported to have performed tooth extractions and 52.3% implant surgery in patients under anti-resorptive therapy for osteometabolic disorders. One or more MRONJ-affected patients were encountered by 63.2% of the respondents. This survey highlights the need to develop a "dedicated" program both for dentists and prescribers to improve the level of cooperation and to increase the level of awareness of patients treated with anti-resorptive agents.
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Acharya, S., Patil, V., Ravindranath, V., Kudva, A., & Nikhil, K. (2022). Medication-related osteonecrosis of the jaw: Knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals. Journal of Medicine and Life, 15(3), 368-373. https://doi.org/10.25122/jml-2021-0085
Aimetti, M., Perotto, S., Castiglione, A., Mariani, G. M., Ferrarotti, F., & Romano, F. (2015). Prevalence of periodontitis in an adult population from an urban area in North Italy: Findings from a cross-sectional population-based epidemiological survey. Journal of Clinical Periodontology, 42(7), 622-631. https://doi.org/10.1111/jcpe.12420
AIOM. (2022). I Numeri del Cancro in Italia (p. 2022). AIOM. https://www.aiom.it/wp-content/uploads/2022/12/2022_AIOM_NDC-web.pdf
Al-Eid, R., Alduwayan, T., Bin Khuthaylah, M., & Al Shemali, M. (2020). Dentists' knowledge about medication-related osteonecrosis of the jaw and its management. Heliyon., 6(7), e04321. https://doi.org/10.1016/j.heliyon.2020.e04321
Al-Samman, A. A., & Al-Ani, R. S. (2019). Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society. Journal of Cranio-Maxillo-Facial Surgery, 47(6), 926-931. https://doi.org/10.1016/j.jcms.2019.02.006
Cairo, F., Landi, L., Gatti, C., Rasperini, G., & Aimetti, M. (2018). The Italian Society of Periodontology and Implantology. Tooth loss and dental implant outcomes - where is dentistry going? A survey, the Italian Society of Periodontology and Implantology. Oral Diseases, 24(7), 1379-1381.
Calderaro, S., Bausch, K., Tourbier, C., Wetterauer, C., Thieringer, F. M., & Berg, B. I. (2023). Medication-related osteonecrosis of the jaw: A cross-sectional survey among urologists in Switzerland, Germany, and Austria. Journal of Clinical Medicine, 12, 638. https://doi.org/10.3390/jcm12020638
Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., Fusco, V., Gabriele, M., & Bedogni, A. (2020). Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. International Journal of Environmental Research and Public Health, 17, 1-15. https://doi.org/10.3390/ijerph17165998
Chang, C. T., Liu, S. P., Muo, C. H., Tsai, C. H., & Huang, Y. F. (2017). Dental prophylaxis and osteoradionecrosis: A population-based study. Journal of Dental Research, 96(5), 531-538. https://doi.org/10.1177/0022034516687282
Choi, Y., Park, H., Hong, N., Rhee, Y., & Park, W. (2022). Qualitative focus group interview study of communication between patients, dentists and physicians for efficient osteonecrosis of the jaw practices. BMJ Open, 12(3), 1-9. https://doi.org/10.1136/bmjopen-2021-051054
Cuozzo, A., Iorio-Siciliano, V., Vaia, E., Mauriello, L., Blasi, A., & Ramaglia, L. (2022). Incidence and risk factors associated to medication-related Osteo necrosis of the jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study, journal of stomatology. Oral and Maxillofacial Surgery, 123(6), 616-621. https://doi.org/10.1016/j.jormas.2022.03.020
Escovedo, M., García-Consuegra, L., Junquera, S., Olay, S., Ascani, G., & Junquera, L. (2018). Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain). Journal of Stomatology, Oral and Maxillofacial Surgery, 119(5), 395-400. https://doi.org/10.1016/j.jormas.2018.04.008
Everts-Graber, J., Lehmann, D., Burkard, J. P., Schaller, B., Gahl, B., Häuselmann, H. J., Studer, U., Ziswiler, H. R., Reichenbach, S., & Lehmann, T. (2022). Risk of osteonecrosis of the jaw under Denosumab compared to bisphosphonates in patients with osteoporosis. Journal of Bone and Mineral Research, 37, 340-348. https://doi.org/10.1002/jbmr.4472
Fujieda, Y., Doi, M., Asaka, T., Ota, M., Hisada, R., Ohnishi, N., Kono, M., Kameda, H., Nakazawa, D., Kato, M., Amengual, O., & Atsumi, T. (2020). Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. Journal of Bone and Mineral Metabolism, 38, 1-8. https://doi.org/10.1007/s00774-020-01089-y
Gaudin, E., Seidel, L., Bacevic, M., Rompen, E., & Lambert, F. (2015). Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: A systematic review and meta-analysis. Journal of Clinical Periodontology, 42, 922-932. https://doi.org/10.1111/jcpe.12455
Gregson, C. L., Armstrong, D. J., Bowden, J., Cooper, C., Edwards, J., Nittoes, N. J. L., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., Poole, K. E., Reid, D. M., & Compston, J. (2022). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 17, 58. https://doi.org/10.1007/s11657-022-01061-5
Hilder, J., Gray, L., Stubbe, M., Duncan, S., & Dowell, A. C. (2020). OUP accepted manuscript. Family Practice, 1-7, 246-252. https://doi.org/10.1093/fampra/cmaa122
Kassebaum, N. J., Bernabé, E., Dahiya, M., Bhandari, B., Murray, C. J., & Marcenes, W. (2014). Global burden of severe periodontitis in 1990-2010: A systematic review and meta-regression. Journal of Dental Research, 93(11), 1045-1053. https://doi.org/10.1177/0022034514552491
Landi, L., Leali, P. T., Barbato, L., Carrassi, A. M., Discepoli, N., Muti, P. C. M., Oteri, G., Rigoni, M., Romanini, E., Ruggiero, C., Tarantino, U., Varoni, E., Sforza, N. M., & Brandi, M. L. (2023). Anti-resorptive therapy in the osteometabolic patient affected by periodontitis. A joint position paper of the Italian Society of Orthopaedics and Traumatology (SIOT) and the Italian Society of Periodontology and Implantology (SIdP). Journal of Orthopaedics and Traumatology, 24(1), 36. https://doi.org/10.1186/s10195-023-00713-
Levin, C. K., Baker, J., Nolan, P., & Coffey, A. (2020). A survey of medication-related osteonecrosis of the jaw reporting and risk assessment by oral and maxillofacial surgeons. Journal of Oral and Maxillofacial Surgery, 78(10), E90-E91. https://doi.org/10.1016/J.joms2020.07.179
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., & Go, A. S. (2010). Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. Journal of Oral and Maxillofacial Surgery, 68(2), 243-253. https://doi.org/10.1016/j.joms.2009.03.050
Marx, R. E. (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. Journal of Oral and Maxillofacial Surgery, 61(9), 1115-1117. https://doi.org/10.1016/s0278-2391(03)00720-1
Mauceri, R., Coniglio, R., Abbinante, A., Carcieri, P., Tomassi, D., Panzarella, V., Di Fede, O., Bertoldo, F., Fusco, V., Bedogni, A., & Campisi, G. (2022). The preventive care of medication-related osteonecrosis of the jaw (MRONJ): A position paper by Italian experts for dental hygienists. Supportive Care in Cancer, 30, 6429-6440. https://doi.org/10.1007/s00520-022-06940-8
Migliorati, C. A., Mattos, K., & Palazzolo, M. J. (2010). How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care. Journal of the American Dental Association, 141, 562-566. https://doi.org/10.14219/jada.archive.2010.0229
Nisi, M., Karapetsa, D., Gennai, S., Ramaglia, L., Graziani, F., & Gabriele, M. (2018). Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up. Journal of Cranio-Maxillo-Facial Surgery, 46(7), 1153-1158. https://doi.org/10.1016/j.jcms.2018.05.003
Nuti, R., Brandi, M. L., Checchia, G., Di Munno, O., Dominguez, L., Falaschi, P., & Isaia, G. C. (2019). Guidelines for the management of osteoporosis and fragility fractures. Internal and Emergency Medicine, 14(1), 85-102. https://doi.org/10.1007/s11739-018-1874-2
Osservatorio Nazionale per l'Impiego dei Farmaci. (2022). L'Uso dei Farmaci in Italia. Rapporto Nazionale Anno. https://www.aifa.gov.it/documents/20142/1967301/Rapporto-OsMed-2022.pdf
Ramaglia, L., Guida, A., Iorio-Siciliano, V., Cuozzo, A., Blasi, A., & Sculean, A. (2018). Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: A systematic review and meta-analysis of the drug suspension protocol. Clinical Oral Investigations, 22, 597-615. https://doi.org/10.1007/s00784-017-2325-6
Raspini, M., Cavalcanti, R., Clementini, M., Crea, A., Di Stefano, M., Fratini, A., Karaboue, M., Lacasella, G. V., Landi, L., Larussa, R., Littarru, C., Sforza, N. M., & Cairo, F. (2021). La Parodontite e gli italiani nel periodo 2016-2020: Informazione, formazione e necessità di linee guida per una strategia efficace nel controllo della malattia. Dental Cadmos, 89(5), 346-356. https://doi.org/10.19256/d.cadmos.05.2021.05
Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022). American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. Journal of Oral and Maxillofacial Surgery, 80(5), 920-943. https://doi.org/10.1016/j.joms.2022.02.008
SDCEP. (2017). Oral health management of patients at risk of medication-related osteonecrosis of the jaw. Dental clinical guidance. SDCEP. https://www.sdcep.org.uk/media/m0ko0gng/sdcep-oral-health-management-of-patients-at-risk-of-mronj-guidance-full.pdf
Sturrock, A., Preshaw, P. M., Hayes, C., & Wilkes, S. (2019). Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): A qualitative study in England. BMJ Open, 9(3), 1-7. https://doi.org/10.1136/bmjopen-2018-024376
Taguchi, A., Shiraki, M., Sugimoto, T., Ohta, H., & Soen, S. (2016). Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw. Current Medical Research and Opinion, 32, 1261-1268. https://doi.org/10.1185/03007995.2016.1170005
Tanna, N., Steel, C., Stagnell, S., & Bailey, E. (2017). Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners. British Dental Journal, 222(2), 121-125. https://doi.org/10.1038/sj.bdj.2017.79
Willers, C., Norton, N., Harvey, N. C., Jacobson, T., Johansson, H., Lorentzon, M., McCloskey, E. V., Borgström, F., Kanis, J. A., & the SCOPE review panel of IOF. (2022). Osteoporosis in Europe: A compendium of country-specific reports. Archives of Osteoporosis, 17, 23. https://doi.org/10.1007/s11657-021-00969-8
Yamori, M., Tamura, M., Mikami, M., Mori, T., Noi, M., Machida, Y., Koshinuma, S., & Yamamoto, G. (2021). Differences in the knowledge and experience of physicians and dentists about medication-related osteonecrosis of the jaw in osteoporotic patients. International Dental Journal, 71(4), 336-342. https://doi.org/10.1016/j.identj.2020.12.005
Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., Urade, M., Shibahara, T., & Toyosawa, S. (2017). Antiresorptive agent-related osteonecrosis of the jaw: Position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism, 35, 6-19. https://doi.org/10.1007/s00774-016-0810-7